IL165889A0 - Use of metal complexes containing perfluoroalkyl as contrast agents in magnetis resonance imaging for representing imtravascular thrombi - Google Patents

Use of metal complexes containing perfluoroalkyl as contrast agents in magnetis resonance imaging for representing imtravascular thrombi

Info

Publication number
IL165889A0
IL165889A0 IL16588904A IL16588904A IL165889A0 IL 165889 A0 IL165889 A0 IL 165889A0 IL 16588904 A IL16588904 A IL 16588904A IL 16588904 A IL16588904 A IL 16588904A IL 165889 A0 IL165889 A0 IL 165889A0
Authority
IL
Israel
Prior art keywords
imtravascular
magnetis
thrombi
representing
resonance imaging
Prior art date
Application number
IL16588904A
Other languages
English (en)
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL165889A0 publication Critical patent/IL165889A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL16588904A 2002-07-10 2004-12-21 Use of metal complexes containing perfluoroalkyl as contrast agents in magnetis resonance imaging for representing imtravascular thrombi IL165889A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10231799A DE10231799B4 (de) 2002-07-10 2002-07-10 Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Intravasalen Thromben
PCT/EP2003/007274 WO2004006965A2 (fr) 2002-07-10 2003-07-05 Utilisation de complexes metalliques contenant du perfluoroalkyle en tant qu'agents de contraste en imagerie par resonance magnetique pour la representation de thrombus intravasculaires

Publications (1)

Publication Number Publication Date
IL165889A0 true IL165889A0 (en) 2006-01-15

Family

ID=30009959

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16588904A IL165889A0 (en) 2002-07-10 2004-12-21 Use of metal complexes containing perfluoroalkyl as contrast agents in magnetis resonance imaging for representing imtravascular thrombi

Country Status (23)

Country Link
EP (1) EP1519756B1 (fr)
JP (1) JP2005532404A (fr)
CN (1) CN1668338A (fr)
AR (1) AR041187A1 (fr)
AT (1) ATE361103T1 (fr)
AU (2) AU2003281146A1 (fr)
BR (1) BR0312552A (fr)
CA (1) CA2491933A1 (fr)
DE (2) DE10231799B4 (fr)
DK (1) DK1519756T3 (fr)
ES (1) ES2285143T3 (fr)
IL (1) IL165889A0 (fr)
MX (1) MXPA04012950A (fr)
NO (1) NO20050679L (fr)
PE (1) PE20040656A1 (fr)
PL (1) PL374027A1 (fr)
PT (1) PT1519756E (fr)
RS (1) RS20050020A (fr)
RU (1) RU2328310C2 (fr)
TW (1) TW200413008A (fr)
UA (1) UA79294C2 (fr)
WO (2) WO2004006979A2 (fr)
ZA (1) ZA200501172B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006021495A1 (de) * 2006-05-09 2007-11-15 Bayer Schering Pharma Ag Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel zur Diagnose der Alzheimer Krankheit
EP2389361B1 (fr) * 2008-12-05 2016-08-24 Molecular Insight Pharmaceuticals, Inc. Complexes de technétium et de rhénium bis (hétéroaryle) et procédés d'utilisation de ceux-ci pour inhiber le psma
EP3101012A1 (fr) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft Nouveaux composés de chélate de gadolinium pour une utilisation dans l'imagerie par résonance magnétique
CA3044877A1 (fr) 2016-11-28 2018-05-31 Bayer Pharma Aktiengesellschaft Composes de chelate de gadolinium a relaxivite elevee pour utilisation dans l'imagerie par resonance magnetique
CN107445911B (zh) * 2017-06-19 2019-07-05 南京科技职业学院 一种二核含钆磁共振对比剂及其制备与应用
SG11202104657RA (en) 2018-11-23 2021-06-29 Bayer Ag Formulation of contrast media and process of preparation thereof
CN109867635A (zh) * 2019-02-14 2019-06-11 华东师范大学 一种t1型胶束磁共振成像造影剂及其制备方法
EP4059925A1 (fr) 2021-03-15 2022-09-21 Bayer Aktiengesellschaft Nouvel agent de contraste pour une utilisation dans l'imagerie par résonance magnétique
EP4335462A1 (fr) 2022-09-09 2024-03-13 Bayer AG Nouveaux agents de contraste pour l'imagerie diagnostique par tomodensitometrie
EP4335840A1 (fr) 2022-09-09 2024-03-13 Bayer Aktiengesellschaft Nouveaux agents de contraste pour l'imagerie diagnostique

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571498A (en) * 1994-06-02 1996-11-05 Hemagen/Pfc Emulsions of paramagnetic contrast agents for magnetic resonance imaging (MRI).
DE19603033A1 (de) * 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
AU4753997A (en) * 1996-10-16 1998-05-11 Burnham Institute, The Magnetic resonance imaging of thrombi
DE19729013A1 (de) * 1997-07-03 1999-02-04 Schering Ag Oligomere, perfluoralkylhaltige Verbindungen, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
US6019959A (en) * 1997-07-31 2000-02-01 Schering Aktiengesellschaft Oligomeric compounds that contain perfluoroalkyl, process for their production, and their use in NMR diagnosis
DE19914101C1 (de) * 1999-03-22 2000-10-12 Schering Ag Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik
CN1626246A (zh) * 1999-07-29 2005-06-15 埃匹克斯医药品股份有限公司 通过多位点结合的寻靶多体造影剂
DE19948651B4 (de) * 1999-09-29 2006-10-05 Schering Ag Para- und diamagnetische perfluorhaltige Verbindungen enthaltende galenische Formulierungen, deren Herstellung und Verwendung
US6565828B2 (en) * 2000-04-07 2003-05-20 Bristol-Myers Squibb Company Macrocyclic chelants for metallopharmaceuticals
DE10040858C2 (de) * 2000-08-11 2003-12-18 Schering Ag Perfluoralkylhaltige Komplexe mit polaren Resten, Verfahren zu deren Herstellung und ihre Verwendung
DE10040381C1 (de) * 2000-08-11 2002-06-06 Schering Ag Perfluoralkylhaltige Komplexe mit Zuckerresten, Verfahren zu deren Herstellung und ihre Verwendung
DE10066210B4 (de) * 2000-08-11 2008-02-28 Bayer Schering Pharma Ag Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Plaques
DE10040380B4 (de) * 2000-08-11 2006-03-09 Schering Ag Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Plaques

Also Published As

Publication number Publication date
RU2005103598A (ru) 2005-11-20
BR0312552A (pt) 2005-04-26
ATE361103T1 (de) 2007-05-15
AU2003281150A1 (en) 2004-02-02
EP1519756B1 (fr) 2007-05-02
MXPA04012950A (es) 2005-05-16
WO2004006979A2 (fr) 2004-01-22
DE10231799B4 (de) 2006-10-05
TW200413008A (en) 2004-08-01
PT1519756E (pt) 2007-07-12
UA79294C2 (en) 2007-06-11
PL374027A1 (en) 2005-09-19
DE10231799A1 (de) 2004-02-12
DE50307180D1 (de) 2007-06-14
AR041187A1 (es) 2005-05-04
AU2003281146A1 (en) 2004-02-02
CN1668338A (zh) 2005-09-14
EP1519756A2 (fr) 2005-04-06
WO2004006965A2 (fr) 2004-01-22
ES2285143T3 (es) 2007-11-16
DK1519756T3 (da) 2007-08-13
PE20040656A1 (es) 2004-12-01
JP2005532404A (ja) 2005-10-27
RS20050020A (en) 2007-08-03
CA2491933A1 (fr) 2004-01-22
RU2328310C2 (ru) 2008-07-10
ZA200501172B (en) 2006-04-26
NO20050679L (no) 2005-04-08
WO2004006965A3 (fr) 2004-07-15

Similar Documents

Publication Publication Date Title
AU2003224374A1 (en) Reduction of susceptibility artifacts in subencoded single-shot magnetic resonance imaging
IL160179A0 (en) Apparatus and methods for in vivo imaging
EP1379885A4 (fr) Agent ameliorateur de contraste en imagerie par resonance magnetique
AU2003225287A8 (en) Magnetic resonance imaging
AU2003302229A8 (en) Imaging by magnetic resonance adsorption, elastography and tomography
IL160879A0 (en) Methods and apparatus for motion compensation in image reconstruction
EP1593091A4 (fr) Methode d'imagerie optoacoustique a contraste eleve utilisant des nanoparticules
PL1824523T3 (pl) Sposób obrazowania serca przy zastosowaniu hiperspolaryzowanego 13C-pirogronianu
AU2003230167A8 (en) Imaging methods and apparatus particularly useful for two and three-dimensional angiography
EP1499292A4 (fr) Imagerie de l'apoptose in vivo
EP1450863A4 (fr) Procedes d'imagerie vasculaire comprenant l'utilisation d'agents de contraste nanoparticulaires
GB2422743B (en) Reducing artifacts in compressed images
AU2002256311A1 (en) Artifact suppression in dynamic magnetic resonance imaging
IL165889A0 (en) Use of metal complexes containing perfluoroalkyl as contrast agents in magnetis resonance imaging for representing imtravascular thrombi
IL157349A0 (en) Method and apparatus for the non-invasive imaging of anatomic tissue structures
GB2401428B (en) Open-sided patient care unit
HUP0300736A3 (en) Use of metal complexes containing perfluoroalkyl as contrast agents in mri-imaging for the representation of plaques, tumours and necroses
AU2001277549A1 (en) Use of metal complexes containing perfluoroalkyl as contrast agents in mr-imaging for the representation of plaques, tumours and necroses
IL157024A0 (en) Il-18 inhibitors in heart disease
IL153183A0 (en) Agents for imaging and diagnostic methods using them
AU2003245351A8 (en) Magnetic resonance imaging of metal concentrations
AU2003233431A8 (en) Protamine-adenoviral vector complexes and methods of use
AU2003295288A8 (en) Magnetic resonance imaging method and compounds for use in the method
GB2394794B (en) Reduction of wear on selected components in multi-colour imaging apparatus
AU2003255991A1 (en) Catheter for use in mr imaging